Media
JP Morgan initiates coverage on Blueprint Medicines, highlighting Ayvakit’s significant growth, 2024 revenue forecast, and potential strategic...
Shrub (CRYPTO: SHRUB), the new pet of Elon Musk‘s family, is trading more than 3,300% higher in...
An aging U.S. population is increasing demand for home health care. The Optum-Amedisys merger, with divestitures to...
A Chipotle shareholder is suing the company, claiming they faced “significant losses” due to the alleged portion-size...